Evidence map›Paper›PMID 27516545›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Unreplicated DNA remaining from unperturbed S phases passes through mitosis for resolution in daughter cells.

Alberto Moreno, Jamie T Carrington, Luca Albergante, Mohammed Al Mamun, Emma J Haagensen, Eirini-Stavroula Komseli, Vassilis G Gorgoulis, Timothy J Newman, J Julian Blow

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 136 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Mitotic chromatin marking governs asymmetric segregation of DNA damage.bioRxiv : the preprint server for biology · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Alberto MorenoSchool of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;
Jamie T CarringtonSchool of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;
Luca AlberganteSchool of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom; School of Science and Engineering, University of Dundee, Dundee DD1 4HN, United Kingdom;ORCID 0000-0001-8151-6989
Mohammed Al MamunSchool of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom; School of Science and Engineering, University of Dundee, Dundee DD1 4HN, United Kingdom;
Emma J HaagensenSchool of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom;
Eirini-Stavroula KomseliDepartment of Histology and Embryology, School of Medicine, University of Athens, GR-11527 Athens, Greece;
Vassilis G GorgoulisDepartment of Histology and Embryology, School of Medicine, University of Athens, GR-11527 Athens, Greece; Biomedical Research Foundation of the Academy of Athens, GR-11527 Athens, Greece; Faculty Institute of Cancer Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester M20 4QL, United Kingdom.
Timothy J NewmanSchool of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom; School of Science and Engineering, University of Dundee, Dundee DD1 4HN, United Kingdom;
J Julian BlowSchool of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom; j.j.blow@dundee.ac.uk.
University of Dundee · GBNational and Kapodistrian University of Athens · GR

Funding

Medical Research Council MR/K015869/1Wellcome Trust
6 · The paper itself

Abstract

To prevent rereplication of genomic segments, the eukaryotic cell cycle is divided into two nonoverlapping phases. During late mitosis and G1 replication origins are "licensed" by loading MCM2-7 double hexamers and during S phase licensed replication origins activate to initiate bidirectional replication forks. Replication forks can stall irreversibly, and if two converging forks stall with no intervening licensed origin-a "double fork stall" (DFS)-replication cannot be completed by conventional means. We previously showed how the distribution of replication origins in yeasts promotes complete genome replication even in the presence of irreversible fork stalling. This analysis predicts that DFSs are rare in yeasts but highly likely in large mammalian genomes. Here we show that complementary strand synthesis in early mitosis, ultrafine anaphase bridges, and G1-specific p53-binding protein 1 (53BP1) nuclear bodies provide a mechanism for resolving unreplicated DNA at DFSs in human cells. When origin number was experimentally altered, the number of these structures closely agreed with theoretical predictions of DFSs. The 53BP1 is preferentially bound to larger replicons, where the probability of DFSs is higher. Loss of 53BP1 caused hypersensitivity to licensing inhibition when replication origins were removed. These results provide a striking convergence of experimental and theoretical evidence that unreplicated DNA can pass through mitosis for resolution in the following cell cycle.

Indexed as

MitosisS PhaseBronchiCell Cycle ProteinsDNAEpithelial CellsGenetic LociHeLa CellsHistonesHumansNuclear ProteinsReplication OriginRNA InterferenceTumor Suppressor p53-Binding Protein 1CDC6 protein, humanCell Cycle ProteinsDNAH2AX protein, humanHistonesMCM5 protein, humanNuclear ProteinsTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 153BP1cell cycleDNA replicationMCMUFB

Identifiers

PMID27516545
PMCPMC5047195
OpenAlexW2515420023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.